Blueprint Medicines News

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.

Jun 14 17:45 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director COATS LONNEL

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Beckman Daniella

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Tsai John

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Seely Lynn

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Lydon Nicholas

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Goldberg Mark Alan

Jun 14 17:35 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Borisy Alexis

Jun 14 17:35 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Dable Habib J

Jun 14 17:35 ET

Blueprint Medicines | 8-K: Current report

Jun 14 16:06 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Carter Percy H.

Jun 7 16:02 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Hewes L. Becker

Jun 6 16:02 ET

Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 5 17:12 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Carter Percy H.

Jun 5 16:02 ET

Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 4 16:44 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Hewes L. Becker

Jun 4 16:04 ET

Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 3 16:32 ET

Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144

May 31 16:58 ET

Blueprint Medicines | 8-K: Current report

May 24 08:01 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Hurley Ariel

May 17 16:13 ET